Steve’s Story
Find out more about how Cure Leukaemia's funding impacts patients in Birmingham and surrounding areas
Cure Leukaemia is proud to play a vital role in supporting blood cancer patients across Birmingham. At the Queen Elizabeth Hospital, we fund a dedicated clinical research nurse who ensures patients have access to pioneering treatments and potentially life-saving clinical trials.
Our support also extends to young patients and their families, with Birmingham Children’s Hospital being an important part of the ATICUS Network – a groundbreaking initiative bringing together leading centres to deliver world-class care and research opportunities.
Together, these efforts help to provide hope, innovation, and improved outcomes for people facing blood cancer in our city.

Discover which clinical trials have been delivered in Birmingham, with support of funding from Cure Leukaemia
The VICTOR trial is a groundbreaking clinical trial available at TAP Centres across the UK, comparing a combination of two targeted drugs to traditional chemotherapy. This trial, specifically designed for AML patients aged 60 and over, offered a less toxic and more manageable treatment option.
Focused on patients with Myelofibrosis, the Fedora trial is tackling a critical area of unmet need, gathering information about whether a combination of treatments is tolerated, and whether it provides a therapeutic benefit to patients. The FEDORA Trial has now completed recruitment, with results expected to be published soon.
One of the TAP Network’s highest recruiting studies, AMMO trial tests a new drug in treating and extending the lives of patients with a rare bone marrow cancer, where treatment options are very limited. The treatment can be taken orally at home, making it much more convenient for patients. The trial has just concluded and results are expected to be published at the end of 2025.
Steve’s Story
Morgan’s Story
Rob’s Story
Adam’s Story
Moonii’s Story
Steve’s Story
Get involved in some of our upcoming events in Birmingham and raise vital funds to help us continue to support patients across the region